NASDAQ · Medical - Diagnostics & Research

Check-Cap Ltd. (CHEK) Stock

$1.86 +1.64% NASDAQ: CHEK Healthcare

Check-Cap Ltd. is an Israeli medical diagnostics company currently in the clinical development phase.

Valuation

MetricValue
Price$1.86
Market Cap$10.88M
P/E Ratio-0.43
P/B Ratio-7.50
P/S Ratio0.00
EPS (TTM)$-4.30
52-Week High$3.13
52-Week Low$0.56
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-226.19%
ROA—
ROCE—
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.09
Current Ratio0.15

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$-14.0M$-17.0M$-20.0M$-19.0M$-26.0M
Net Profit$-14.0M$-17.0M$-19.0M$-18.0M$-25.0M
EPS$-9.12$-4.13$-3.37$-3.00$-4.30
Op Margin—————

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$20.0M$56.0M$45.0M$25.0M$0
Total Liabilities$3.0M$5.0M$4.0M$1.0M$2.0M
Cash$8.0M$26.0M$4.0M$9.0M$0
Borrowings$0$1.0M$1.0M$0$0

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-13.0M$-16.0M$-19.0M$-17.0M$0
Investing Cash Flow$-11.0M$-32.0M$-25.0M$43.0M$0
Financing Cash Flow$0$19.0M$0$0$0
Net Cash Flow$0$19.0M$-22.0M$4.0M$0
Free Cash Flow$-13.0M$-17.0M$-19.0M$-17.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-1.16
FCF Yield-0.07%
Quick Ratio0.15
Interest Coverage-2883.22
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACXPAcurx Pharmaceuticals, Inc. $1.27 +1.60% -0.36 $5.46M 0.00%
ADILAdial Pharmaceuticals, Inc $3.90 -1.76% -0.26 $10.24M 0.00%
BFRIBiofrontera Inc. $0.97 +5.57% -1.69 $12.42M 0.00%
GBSGBS Inc. $0.47 -1.58% -0.18 $433577 0.00%
HCWBHCW Biologics Inc. $1.60 +4.58% -0.03 $556226 0.00%

About Check-Cap Ltd.

Check-Cap Ltd. is an Israeli medical diagnostics company currently in the clinical development phase. It is dedicated to advancing a novel capsule-based screening method that employs ultra-low-dose X-rays. This technology is designed to thoroughly examine the internal surface of the colon, aiming to identify precancerous polyps and other structural irregularities. The company's primary offering, the C-Scan system, is composed of three integral parts: the C-Scan Cap, an ingestible X-ray scanning capsule for detecting suspected polyps; the C-Scan Track, a disposable unit that adheres to the patient's back via biocompatible adhesive patches; and the C-Scan View software. This client/server application enables the download of procedural data from the C-Scan Track, performs detailed analysis, and generates comprehensive reports. Check-Cap Ltd. was founded in 2004 and operates from its headquarters in Isfiya, Israel.

Check-Cap Ltd. is headquartered in IL.

Check-Cap Ltd. (CHEK) stock trades at $1.86 with a market capitalization of $10.88M. The stock is valued at a price-to-earnings (P/E) ratio of -0.43, price-to-book of -7.50, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.56 and $3.13, and currently trades 40.6% below its 52-week high.

On profitability, Check-Cap Ltd. generates a return on equity (ROE) of -226.19%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.check-cap.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides